Epidiolex – Mediccanna

European panel okays GW Pharma cannabis drug for epilepsy

Post author:julia.rsoholland@gmail.com
Post published:13/08/2019
Post category:News
Post comments:0 Comments

GW Pharmaceuticals' marijuana-based treatment Epidyolex has won a positive recommendation for marketing approval from a European Medicines Agency (EMA) panel on Friday for use as an additional treatment for two…

GW Pharma’s cannabis-based epilepsy drug meets main goal in a late-stage trial

Post author:julia.rsoholland@gmail.com
Post published:21/06/2019
Post category:News
Post comments:0 Comments

May 6 (Reuters) - GW Pharmaceuticals Plc said on Monday its drug Epidiolex was successful in treating seizures in patients with a rare form of childhood epilepsy called tuberous sclerosis…